π FDA Panel Reviews Blood Test That Screens for 50 Cancers An independent FDA advisory panel is reviewing Grail's Galleri blood test, which claims to detect up to 50 forms of cancer from a single blood draw. The panel's recommendation could influence whether the test receives FDA approval and, subsequently, Medicare coverage. A major clinical study failed to prove the test could detect later-stage cancers, raising a significant evidentiary hurdle for the company. FDA advisers will vote on whether to recommend the test for approval. Source
Open in Telegram
π FDA Panel Reviews Blood Test That Screens for 50 Cancers
Views2,003+10%vs avg
Forwards3
Reactionsβ
Commentsβ
Views growth
Hours after publication
Show as table
| Hours after publication | Views |
|---|---|
| 0 h | 1 |
| 13 h | 1,220 |
| 21 h | 1,446 |
| 31 h | 1,706 |
| 42 h | 1,837 |
| 54 h | 1,948 |
| 67 h | 2,003 |
- After 24 hours1,446
- Total to date2,003
More from INSIDER | News | Politics | USA
- 01Views2.73KForwards4Reactions11Commentsβ
- 02Views2.58KForwards9Reactions9Commentsβ
- 03Views2.53KForwards3Reactions8Commentsβ
- 04Views2.38KForwards1Reactions6Commentsβ
- 05Views2.36KForwards1Reactions5Commentsβ